Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma

Spatial regulation of bone morphogenetic proteins (BMPs) in postnatal articular and growth plate cartilage

(2017) Presley Garrison et al.   PLoS One

The ins and outs of lncRNA structure: How, why and what comes next?

(2016) Amanda J. Blythe et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Long Noncoding RNAs in Cancer Pathways

(2016) Adam M. Schmitt et al.   CANCER CELL

Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study

(2016) Jia Hui Ng et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography

(2016) Daniel S.W. Tan et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)

(2016) María Echarri et al.   Cancers

Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer

(2015) Filippo Lococo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

(2015) Assuntina G. Sacco et al.   JOURNAL OF CLINICAL ONCOLOGY

The landscape of long noncoding RNAs in the human transcriptome

(2015) Matthew K Iyer et al.   NATURE GENETICS

The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma

(2015) Hao-long Qi et al.   TUMOR BIOLOGY

RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients

(2015) Talia Golan et al.   Oncotarget

Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance

(2015) Andre Luiz Vettore et al.   Genome Medicine

Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients

(2015) Elena Yaiza Romero-Ventosa et al.   SpringerPlus

Epidemiology of Oral Cancer in Asia in the Past Decade- An Update (2000-2012)

(2014) Sree Vidya Krishna Rao et al.   Asian Pacific Journal of Cancer Prevention

Tongue carcinoma infrequently harbor common actionable genetic alterations

(2014) Daniel SW Tan et al.   BMC CANCER

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix

(2014) Jessica A Brown et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Targeting Cancer Stem Cell Plasticity Through Modulation of Epidermal Growth Factor and Insulin-Like Growth Factor Receptor Signaling in Head and Neck Squamous Cell Cancer

(2014) Hui Sun Leong et al.   Stem Cells Translational Medicine

Changing Trends in Smoking and Alcohol Consumption in Patients With Oral Cancer Treated at Memorial Sloan-Kettering Cancer Center From 1985 to 2009

(2013) Pablo H. Montero et al.   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers

(2011) E.-H. Tan et al.   ANNALS OF ONCOLOGY

NanoStriDE: normalization and differential expression analysis of NanoString nCounter data

(2011) Christopher D Brumbaugh et al.   BMC BIOINFORMATICS

Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor Predicts Outcome after Chemoradiotherapy of Lymph Node–Negative Cervical Cancer

(2011) Cathinka Halle et al.   CLINICAL CANCER RESEARCH

Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain

(2011) ANGÉLIQUE GUILLAUDEAU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells

(2011) Kamila A. Adamczyk et al.   LIFE SCIENCES

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

(2010) L. Licitra et al.   ANNALS OF ONCOLOGY

Biomarker-Driven Early Clinical Trials in Oncology

(2010) Daniel S. W. Tan et al.   CANCER JOURNAL

Epidermal growth factor receptor targeted therapy in stage III and IV head and neck cancer

(2010) C. Cripps et al.   Current Oncology

EGFR isoforms and gene regulation in human endometrial cancer cells

(2010) Lina Albitar et al.   Molecular Cancer

Phase III Study of Gefitinib Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck

(2009) J. Simon W. Stewart et al.   JOURNAL OF CLINICAL ONCOLOGY

Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck

(2009) Ezra Eddy Wyssam Cohen et al.   ORAL ONCOLOGY

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

(2008) Jan B. Vermorken et al.   NEW ENGLAND JOURNAL OF MEDICINE

Global epidemiology of oral and oropharyngeal cancer

(2008) Saman Warnakulasuriya   ORAL ONCOLOGY